NCT06656819

Brief Summary

The goal of this project is to test our central hypothesis that the spinal cord neuroplasticity in females will be modulated by the level of estradiol concentration. under aim 1 we will determine the influence of estradiol fluctuations on spinal circuit excitability post afferent (sensory) mediated subthreshold motor priming in young healthy females and males. We will use an established repetitive peripheral nerve electrical stimulation with a stimulation intensity below the motor threshold to prime the spinal motor circuits. under aim 2 we seek to characterize the input output property of spinal circuit excitability after descending drive (motor) mediated priming in young healthy male participants. in aim 3 we will examine the influence of estradiol fluctuations on descending drive mediated motor priming in young healthy females.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
20mo left

Started Jul 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Jul 2020Dec 2027

Study Start

First participant enrolled

July 1, 2020

Completed
4.1 years until next milestone

First Submitted

Initial submission to the registry

August 21, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 24, 2024

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

March 30, 2026

Status Verified

February 1, 2026

Enrollment Period

7.5 years

First QC Date

August 21, 2024

Last Update Submit

March 25, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in Spinal circuit excitability

    Change in Spinal circuit excitability will be assessed by measuring Hoffmann reflex/ M wave ratio of the soleus muscle. Higher scores indicate poorer outcome.

    Baseline 1, Post-60mins after peripheral nerve stimulation

  • Change in Motor neuron excitability

    Changes in motor neuron excitability, as quantified by Delta-F values.

    Baseline 2, Post-60mins after priming

  • Change in spinal reflex expression

    Baseline 2, Post-60mins after priming

  • Change in descending drive mediated motor priming

    Baseline 2, Post-60mins after priming

Study Arms (2)

Healthy Females

Device: Magstim Rapid2

Healthy Males (control)

Device: Magstim Rapid2

Interventions

AIM 1: Investigate the estradiol effect on spinal circuit excitability post afferent (sensory) mediated subthreshold motor priming in young healthy women and men. AIM 2: Characterize the Input output property of spinal circuit excitability following descending drive (motor) mediate priming in young healthy participants AIM 3: Examine the estradiol effect on spinal circuit excitability following descending drive (motor) mediated priming in young healthy females

Healthy FemalesHealthy Males (control)

Eligibility Criteria

Age18 Years - 39 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

(1) Healthy females (2) Healthy males (control)

You may qualify if:

  • Ages 18-39 years
  • Eumenorrheic (regular monthly cycles of 24-35 days)
  • Moderately active (less than 7 hours of vigorous physical activity per week)
  • History of pregnancy is allowed if patient is in post-lactation phase

You may not qualify if:

  • History of musculoskeletal or orthopedic injury of the spine, hip, knee, ankle or foot
  • History of neurological injury of the peripheral or central nervous system
  • Current smoker
  • History of disordered eating
  • History of stress fracture in the lower limb
  • History of a connective tissue disorder (Marfan's syndrome, Ehlers-Danlos disease)
  • Pacemaker, metal implants in the head and spine region
  • Pregnancy
  • On a hormonal contraceptive regimen (oral, transdermal or vaginal)
  • History of menstrual dysfunction (primary or secondary amenorrhea, oligomenorrhea, anovulatory cycles, polycystic ovarian disease)
  • Started or stopped taking oral contraceptives within the previous 6 months
  • Exercise vigorously more than 7 hours per week or currently participating in competitive level sports.
  • MALES
  • Ages 18-39
  • Moderately active (less than 7 hours of vigorous physical activity per week)
  • +7 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas Southwestern Medical Center

Dallas, Texas, 75390, United States

RECRUITING

Study Officials

  • Yasin Dhaher, Ph.D.

    University of Texas Southwestern Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yu-Chen Chung, PT, Ph.D.

CONTACT

Subaryani Soedirdjo, Ph.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 21, 2024

First Posted

October 24, 2024

Study Start

July 1, 2020

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

March 30, 2026

Record last verified: 2026-02

Locations